CXCL8 and breast carcinoma: Breast cancer stem cells were found to secrete IL-8 which increased ERα activity, induced tamoxifen resistance and elevated metastatic potential whereas the pharmacological inhibition of IL-8 counteracted tamoxifen resistance with reduction of metastatic potential (67).